BioLineRx Ltd. (BLRX)

NASDAQ: BLRX · Delayed Price · USD
1.45
0.21 (16.94%)
At close: May 26, 2022 4:00 PM
1.44
-0.01 (-0.69%)
After-hours:May 26, 2022 4:46 PM EDT

Total Valuation

BioLineRx has a market cap or net worth of $69.13 million. The enterprise value is $22.25 million.

Market Cap69.13M
Enterprise Value22.25M

Important Dates

The latest earnings date was Wednesday, May 11, 2022, before market open.

Last Earnings DateMay 11, 2022
Ex-Dividend Daten/a

Share Statistics

BioLineRx has 47.68 million shares outstanding. The number of shares has increased by 27.81% in one year.

Shares Outstanding47.68M
Shares Change (YoY)+27.81%
Shares Change (QoQ)+0.38%
Owned by Insiders (%)n/a
Owned by Institutions (%)7.20%
Float47.19M

Valuation Ratios

PE Ration/a
Forward PEn/a
PS Ration/a
PB Ratio1.09
P/FCF Ration/a
PEG Ration/a
Financial Ratio History

Enterprise Valuation

EV / Earningsn/a
EV / Salesn/a
EV / EBITDAn/a
EV / EBITn/a
EV / FCFn/a

Financial Position

The company has a current ratio of 5.60, with a Debt / Equity ratio of 0.06.

Current Ratio5.60
Quick Ratio5.58
Debt / Equity0.06
Debt / EBITDAn/a
Debt / FCFn/a

Financial Efficiency

Return on equity (ROE) is -31.50%, which is considered low.

Return on Equity (ROE)-31.50%
Return on Assets (ROA)-26.10%
Return on Capital (ROIC)n/a
Revenue Per Employeen/a
Profits Per Employee-$573,474
Employee Count38
Asset Turnovern/a
Inventory Turnovern/a

Taxes

Income Taxn/a
Effective Tax Raten/a

Stock Price Statistics

The stock price has decreased by -52.63% in the last 52 weeks. The beta is 1.44, so BioLineRx's price volatility has been higher than the market average.

Beta (1Y)1.44
52-Week Price Change-52.63%
50-Day Moving Average1.36
200-Day Moving Average1.85
Average Volume (30 Days)203,235

Short Selling Information

The latest short interest is 477,400, so 1.00% of the outstanding shares have been sold short.

Short Interest477,400
Short % of Shares Out1.00%
Short % of Float1.01%
Short Ratio (days to cover)1.99

Income Statement

Revenuen/a
Gross Profitn/a
Operating Income-25.41M
Net Income-21.79M
EBITDA-20.21M
EBIT-20.90M
Earnings Per Share (EPS)-$0.47
Full Income Statement

Balance Sheet

The company has $50.59 million in cash and $3.71 million in debt, giving a net cash position of $46.88 million or $0.98 per share.

Cash & Cash Equivalents50.59M
Total Debt3.71M
Net Cash46.88M
Net Cash Per Share$0.98
Book Value63.41M
Book Value Per Share1.33
Working Capital41.84M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$22.93 million and capital expenditures -$96,000, giving a free cash flow of -$23.03 million.

Operating Cash Flow-22.93M
Capital Expenditures-96,000
Free Cash Flow-23.03M
FCF Per Sharen/a
Full Cash Flow Statement

Margins

Gross Marginn/a
Operating Marginn/a
Pretax Marginn/a
Profit Marginn/a
EBITDA Marginn/a
EBIT Marginn/a
FCF Marginn/a

Dividends & Yields

BioLineRx does not appear to pay any dividends at this time.

Dividend Per Sharen/a
Dividend Yieldn/a
Earnings Yield-31.52%
FCF Yield-33.31%
Dividend Growth (YoY)n/a
Payout Ration/a
Buyback Yield-27.81%
Shareholder Yield-27.81%
Dividend Details

Analyst Forecast

Price Targetn/a
Price Target Differencen/a
Analyst Consensusn/a
Analyst Countn/a
Stock Forecasts

Stock Splits

The last stock split was on July 15, 2019. It was a reverse split with a ratio of 1:15.

Last Split DateJul 15, 2019
Split TypeReverse
Split Ratio1:15